Effects of plant protease inhibitors (Pep-3-EcTI, Pep-BbKI, and Pep-BrTI) versus corticosteroids on inflammation, remodeling, and oxidative stress in an asthma-COPD (ACO) model

Autor(es):Mostrar menos -

Joao, Juliana Morelli Lopes Goncalves ; Barbosa, Jessica Anastacia Silva ; da Silva, Luana Laura Sales ; Fukuzaki, Silvia ; de Campos, Elaine Cristina ; Camargo, Leandro do Nascimento ; Santos, Tabata Maruyama dos ; Bezerra, Suellen Karoline Moreira ; de Almeida, Francine Maria ; Saraiva-Romanholo, Beatriz Mangueira ; Lopes, Fernanda Degobbi Tenorio Quirino dos Santos ; Bonturi, Camila Ramalho ; Righetti, Renato Fraga ; Oliva, Maria Luiza Vilela ; Tiberio, Iolanda de Fatima Lopes Calvo ; Leick, Edna Aparecida

• Tipo de documento: Artigo Científico
• Fonte: FRONTIERS IN PHARMACOLOGY; v. 15, p. 21-pg., 2024-05-07.

Resumo

The peptide derived from E. contortisiliquum trypsin inhibitor (Pep-3-EcTI), peptide derived from kallikrein inhibitor isolated from B. bauhinioides (Pep-BbKI), and B. rufa peptide modified from B. bauhinioides (Pep-BrTI) peptides exhibit anti-inflammatory and antioxidant activities, suggesting their potential for treating asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO). We compared the effects of these peptides with dexamethasone (DX) treatment in an ACO model. In this study, 11 groups of male BALB/c mice were pre-treated under different conditions, including sensitization with intraperitoneal injection and inhalation of ovalbumin (OVA), intratracheal instillation of porcine pancreatic elastase (ELA), sensitization with intraperitoneal injection, and various combinations of peptide treatments with Pep-3-EcTI, Pep-BbKI, Pep-BrTI, dexamethasone, and non-treated controls (SAL-saline). Respiratory system resistance, airway resistance, lung tissue resistance, exhaled nitric oxide, linear mean intercept, immune cell counts in the bronchoalveolar lavage fluid, cytokine expression, extracellular matrix remodeling, and oxidative stress in the airways and alveolar septa were evaluated on day 28. Results showed increased respiratory parameters, inflammatory markers, and tissue remodeling in the ACO group compared to controls. Treatment with the peptides or DX attenuated or reversed these responses, with the peptides showing effectiveness in controlling hyperresponsiveness, inflammation, remodeling, and oxidative stress markers. These peptides demonstrated an efficacy comparable to that of corticosteroids in the ACO model. However, this study highlights the need for further research to assess their safety, mechanisms of action, and potential translation to clinical studies before considering these peptides for human use. (AU)

• Processo FAPESP: 18/02537-5 - Caracterização da síndrome de sobreposição asma-DPOC (ACOS): estudos experimentais e clínicos
• Beneficiário: Iolanda de Fátima Lopes Calvo Tibério
• Modalidade de apoio: Auxílio à Pesquisa - Temático